Please login to the form below

Not currently logged in
Email:
Password:

Versiti

This page shows the latest Versiti news and features for those working in and with pharma, biotech and healthcare.

Sanofi and Sobi’s once-weekly haemophilia A treatment approved by FDA

Sanofi and Sobi’s once-weekly haemophilia A treatment approved by FDA

Lynn Malec, medical director of Comprehensive Center for Bleeding Disorders and associate investigator at The Versiti Blood Research Institute, said: “This approval marks an important clinical advancement for the haemophilia community

Latest news

  • Versiti launches test for vaccine-related blood clot issues Versiti launches test for vaccine-related blood clot issues

    These antibodies, says Versiti, are similar to those seen in HIT – when a patient has these antibodies, alternate anticoagulation therapies must be implemented. ... Versiti's long and proud history of scientific discovery in blood clotting puts us in a

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

PMHub

Add my company
Four Health

Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with...

Latest intelligence

Virtual care – negotiating barriers to adoption offers glimpses of an exciting future
Digital tools and innovative healthcare promise to address pressing healthcare issues if they can satisfy concerns over access, security and affordability...
Clinical Trials Investigator and Patient Engagement Planning: A Customer Story
...
New Playbook Alert: Virtual Patient Engagement
...